Correlation Between Pfizer and ADMA Biologics

Can any of the company-specific risk be diversified away by investing in both Pfizer and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and ADMA Biologics, you can compare the effects of market volatilities on Pfizer and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ADMA Biologics.

Diversification Opportunities for Pfizer and ADMA Biologics

-0.18

Correlation Coefficient

Pfizer  ADMA Biologics

Good diversification

The 3 months correlation between Pfizer and ADMA is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of Pfizer i.e., Pfizer and ADMA Biologics go up and down completely randomly.

Pair Corralation between Pfizer and ADMA Biologics

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the ADMA Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.71 times less risky than ADMA Biologics. The stock trades about -0.04 of its potential returns per unit of risk. The ADMA Biologics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,789  in ADMA Biologics on December 26, 2024 and sell it today you would earn a total of  181.00  from holding ADMA Biologics or generate 10.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  ADMA Biologics

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

ADMA Biologics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in ADMA Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, ADMA Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and ADMA Biologics

The main advantage of trading using opposite Pfizer and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.

The idea behind Pfizer Inc and ADMA Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.